337 related articles for article (PubMed ID: 32712720)
1. Clinical significance of serum miR-768-3p in HBV-related hepatocellular carcinoma and its potential mechanism.
Cao C; Wang C
Clin Exp Med; 2020 Nov; 20(4):569-576. PubMed ID: 32712720
[TBL] [Abstract][Full Text] [Related]
2. Potentials as biomarker and therapeutic target of upregulated long non-coding RNA HLA-F antisense RNA 1 in hepatitis B virus-associated hepatocellular carcinoma.
Zhang X; Li W; Li S; Zhang Z; Song W
Virus Genes; 2024 Jun; 60(3):243-250. PubMed ID: 38568442
[TBL] [Abstract][Full Text] [Related]
3. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yu F; Lu Z; Chen B; Dong P; Zheng J
Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P
PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203
[TBL] [Abstract][Full Text] [Related]
5. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
Chen L; Chu F; Cao Y; Shao J; Wang F
Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic significance of serum miR-24-3p in HBV-related hepatocellular carcinoma.
Meng FL; Wang W; Jia WD
Med Oncol; 2014 Sep; 31(9):177. PubMed ID: 25129312
[TBL] [Abstract][Full Text] [Related]
7. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
8. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN
Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of microRNA miR-652-3p is a prognostic risk factor for hepatocellular carcinoma and regulates cell proliferation, migration, and invasion.
Chi X; Jiang Y; Chen Y; Lv L; Chen J; Yang F; Zhang X; Pan F; Cai Q
Bioengineered; 2021 Dec; 12(1):7519-7528. PubMed ID: 34608826
[TBL] [Abstract][Full Text] [Related]
10. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
11. miR-654-3p predicts the prognosis of hepatocellular carcinoma and inhibits the proliferation, migration, and invasion of cancer cells.
Yang J; Zhang Z; Chen S; Dou W; Xie R; Gao J
Cancer Biomark; 2020; 28(1):73-79. PubMed ID: 32176631
[TBL] [Abstract][Full Text] [Related]
12. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening.
Li L; Guo Z; Wang J; Mao Y; Gao Q
Dig Dis Sci; 2012 Nov; 57(11):2910-6. PubMed ID: 22865399
[TBL] [Abstract][Full Text] [Related]
13. Increased Expression of miR-487b Is Associated With Poor Prognosis and Tumor Progression of HBV-Related Hepatocellular Carcinoma.
Cao X; Yang Q; Yu Q
Open Forum Infect Dis; 2020 Dec; 7(12):ofaa498. PubMed ID: 33364257
[TBL] [Abstract][Full Text] [Related]
14. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.
Huang DP; Zeng YH; Yuan WQ; Huang XF; Chen SQ; Wang MY; Qiu YJ; Tong GD
Int J Med Sci; 2021; 18(2):335-346. PubMed ID: 33390802
[No Abstract] [Full Text] [Related]
16. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
Jin Y; Wong YS; Goh BKP; Chan CY; Cheow PC; Chow PKH; Lim TKH; Goh GBB; Krishnamoorthy TL; Kumar R; Ng TP; Chong SS; Tan HH; Chung AYF; Ooi LLPJ; Chang JPE; Tan CK; Lee CGL
Sci Rep; 2019 Jul; 9(1):10464. PubMed ID: 31320713
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
Fei X; Zhang P; Pan Y; Liu Y
Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
[TBL] [Abstract][Full Text] [Related]
18. MiR-222-3p induced by hepatitis B virus promotes the proliferation and inhibits apoptosis in hepatocellular carcinoma by upregulating THBS1.
Sun Y; Shi P; Wu Q; Liu B; Yu Z; Jia H; Chang H
Hum Cell; 2021 Nov; 34(6):1788-1799. PubMed ID: 34273068
[TBL] [Abstract][Full Text] [Related]
19. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection.
Qi P; Cheng SQ; Wang H; Li N; Chen YF; Gao CF
PLoS One; 2011; 6(12):e28486. PubMed ID: 22174818
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of serum exosomal miR-320d predicts poor prognosis in hepatocellular carcinoma.
Li W; Ding X; Wang S; Xu L; Yin T; Han S; Geng J; Sun W
J Clin Lab Anal; 2020 Jun; 34(6):e23239. PubMed ID: 32125733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]